AIMS FELLOWSHIP CURRICULUM TS 3 TRANSFUSION SCIENCE Reference Laboratory Immunohaematology. Reference Laboratory Immunohaematology

Size: px
Start display at page:

Download "AIMS FELLOWSHIP CURRICULUM TS 3 TRANSFUSION SCIENCE Reference Laboratory Immunohaematology. Reference Laboratory Immunohaematology"

Transcription

1 Module Code: TS 3 Module Title: Module Convenor: Discipline Committee: Dr T Cobain SEALS Executive Unit Level 4 Campus Centre The Prince of Wales Hospital Baker St, Randwick, NSW, 2031 Ms Dianne Grey Dr D Roxby Ms D Stern Date Module Outline last reviewed: January 2016 Date Module Outline last modified January

2 A. Objectives This Module is designed to provide the candidate with a sound working knowledge of Transfusion Science as it pertains to the transfusion support of patients, and the investigation of immunohaematological states in a Reference Immunohaematology Laboratory. The Module assumes a basic knowledge of immunohaematological techniques and principles. B. Interrelationship of the Module to Other Modules This Module provides the basis for immunohaematological principles relating to reference laboratory immunohaematology and builds on the immunohaematological investigations covered in TS1. Module TS 1 Core Module: Patient Based Transfusion Science C. Brief Description This Module will provide a sound working knowledge of the immunohaematological principles for the operation of an immunohaematology reference laboratory. D. Content 1. Platelet Antigens and Antibodies 1.1 The genetic basis for platelet HPA-antigens including their gene frequencies. 1.2 The techniques used for HPA-antigen typing. 1.3 The techniques used for the detection of platelet antibodies. 1.4 The clinical consequences of platelet antibody formation, investigation protocols and the principles of treatment for the following clinical settings: a) Foeto-maternal alloimmune thrombocytopenia, b) Platelet transfusion support. c) Autoimmune thrombocytopenias,. d) Post transfusion purpura. 1.5 Drug associated antibodies and their detection. Objective: To understand the techniques and protocols used for platelet antigen and antibody detection and the clinical consequences. 2. Granulocyte Antigens and Antibodies 2.1 The genetic basis for granulocyte antigens including their gene frequencies. 2.2 The techniques used for granulocyte antigen typing.

3 2.3 The techniques used for the detection of granulocyte antibodies. 2.4 The clinical consequences of granulocyte antibody formation. Objective: To understand the techniques used for granulocyte antigen and antibody detection and the clinical consequences. 3 Well Characterised Independent Blood Group Antigens The names and ISBT code numbers of the independent high incidence antigens currently associated with the 901 series. 3.2 The names and ISBT code numbers of the independent low incidence antigens currently associated with the 700 series. Objective: To be familiar with antigens of high and low incidence which are not currently associated with a blood group system. ABO Subgroups and H- deficient Blood Groups 4.1 The serological properties and methodologies used to identify ABO subgroups and H-deficient phenotypes. Objective: To recognise ABO subgroups and H-deficient phenotypes 5 The Complexities of the Rh System 5.1 The molecular biology of the Rh system including Variants of RhD, Weak D, Rh null and Rh mod. 5.2 Low incidence Rh antigens associated with red cells that carry partial D. 5.3 Clinical aspects of the Rh system including the role of molecular genotyping. Objective: To have an understanding of the Rh complex. To be familiar with low incidence antigens associated with partial D. 6 High Titre Low Avidity Antibodies 6.1 The genetic basis for so called HTLA antigens ( Ch/Rg, Knops system, Yk a /Csa, JMH ) including their gene frequencies. 6.2 The principles and technical requirements of current methodologies and procedures used for the identification of HTLA antibodies. 6.3 Clinical significance of HTLA antibodies.

4 Objective: To be thoroughly familiar with the characteristics of HTLA antibodies and the techniques used for identification. 7 Race-related and Other Red Cell Antigens and Alloantibodies 7.1 Then genetic, molecular and biochemical basis for the high and low frequency antigens of the MNSs system and the serological properties of corresponding antibodies. 7.2 Antibodies to high incidence and low incidence antigens in different ethnic backgrounds. Genetic background of red cell null phenotypes in Lu, Ge, Fy, Jk, MNSs, Kell, Cr, Do systems. 7.3 Biological and clinical consequences of red cell null phenotypes, including Kx. 7.4 Implications for transfusion (including sickle cell disease). 7.5 The properties of the antigens and antibodies of the Yt, Do, Di, Co and Cr systems and the clinical significance of the antibodies. 7.6 Polyagglutination and associated antigens. Objective: To be familiar with the high and low incidence antigens associated with established blood group systems and their antibodies, including those found in different ethnic backgrounds and associated with null phenotypes. Awareness of the transfusion, clinical and biological implications. Familiarity with T/Tn system cryptantigens and mechanisms effecting their exposure. 8 Identification of Novel Red Cell Antigens 8.1 The serological (including enzymes and chemical modifications) and molecular techniques available for use in identifying a novel red cell antigen. 8.2 Understanding of the ISBT terminology for Red Cell surface Antigens Objective: To be thoroughly familiar with the process of identifying novel red cell antigens. E Rationale for Content A comprehensive understanding of the scientific principles required for a reference immunohaematology laboratory. F Examination Examination will focus on an overall understanding of the scientific basis of reference immunohaematology laboratory.

5 Under the Fellowship Regulations, a 3-hour written examination will be held at the completion of this Module. The examination will contain a mixture of short answer questions and essay style questions..clinical and laboratory case based scenarios may be included in the question mix. Examination for this Module will focus on an overall understanding of the principles and procedures across the major topic themes : Platelet Antigens and Antibodies Granulocyte Antigens and Antibodies ABO Subgroups and H- deficient Blood Group Systems Complexities of the Rh System High titre low Avidity Antibodies Race related and other red cell antigens and alloantibodies Identification of novel red cell antigens The examination will consist of: 10 short answer questions (5 minutes each total 50 minutes) 5 assay style questions (20 minutes each total 100 minutes) Questions will be divided across the topic themes. The unallocated 30 minutes of the exam period should be devoted to carefully reading the questions and reflecting on your response. G. Texts and Supporting Material The following texts and articles are recommended. In addition current volumes of the recommended journals should be consulted for relevant articles. 1 Issitt PD, Anstee DJ. Applied Blood Group Serology. Montgomery Scientific Publications 4 th Edition Klein HG, Anstee DJ. Molllisons Blood Transfusion in Clinical Medicine. 11 th Edition Technical Manual American Association of Blood banks current Edition 4 Metcalfe P. Platelet antigens and antibody detection. Vox. Sang. 2004; 87: (Suppl 1) S Stroncek D, Granulocyte antigen and antibody detection. Vox. Sang. 2004; 87: (Suppl 1), S Recommended Journals:

6 Transfusion Vox Sanguinis including ISBT Science Series Transfusion Medicine Transfusion Medicine Reviews Immunohaematology H. Appointment of a Mentor Each candidate is required to nominate a mentor for the Module at the time of application for entry and into the Fellowship Program. If a candidate is unable to nominate a mentor then the candidate should contact the Module Convenor for assistance. The appointment of a mentor is made by the Examinations Council. I. Module Communications Module Convenor: Dr T Cobain trevor.cobain@health.nsw.gov.au Discipline Committee: Ms Dianne Grey Dr D Roxby Ms D Stern J. Candidate Feedback Immediately following notification of the examination result each candidate will be asked to complete a feedback questionnaire on the Module. However, feedback at anytime during the study of the Module is encouraged through the mentor or directly to the Module Convenor.

Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017

Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017 Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017 Case Study 1 Patient Demographics -44 year old -African-American Female -Diagnosis: Gastroenteritis -Facility reported

More information

Case Report: Atypical Presentation of Anti-Rg a

Case Report: Atypical Presentation of Anti-Rg a 100 Case Report: Atypical Presentation of Anti-Rg a Eiad Kahwash, Sameer S.Talwalkar, Jill Leonard, and William Lockwood Department of Pathology and Laboratory Medicine, University of Louisville, Louisville,

More information

Immunohematology Case Studies PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB

Immunohematology Case Studies PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB Immunohematology Case Studies 2016-5 PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB fwagner@bsd-nstob.de Clinical History A 78 yrs old patient had coronary artery bypass surgery. In the perioperative

More information

We are actually talking about the Rh Blood Group System!

We are actually talking about the Rh Blood Group System! hr Problems Is this a discussion of your Human Resources nightmares? We are actually talking about the Rh Blood Group System! hr Problems 1 Hr and hr Antigens Hr o (Rh17) Hr or Hr S (Rh18) Hr B (Rh34)

More information

Use and Abuse of Reagents and Techniques. Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA.

Use and Abuse of Reagents and Techniques. Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA. Use and Abuse of Reagents and Techniques Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA. Antibody Screening & Identification Blood Grouping Reference

More information

Immunohematology Practicum Objectives - CLS 645

Immunohematology Practicum Objectives - CLS 645 Clinical Laboratory Sciences Department University of Kansas Medical Center Immunohematology Practicum Objectives - CLS 645 The following objectives are to be completed by the student for successful completion

More information

DIAGNOSTIC SERVICES BC & YUKON

DIAGNOSTIC SERVICES BC & YUKON DIAGNOSTIC SERVICES BC & YUKON YEAR IN REVIEW JANUARY - DECEMBER 31, 2012 Page 1 of 23 CANADIAN BLOOD SERVICES BC & YUKON DIAGNOSTIC SERVICES SENIOR STAFF AND CONTACT INFORMATION Medical Director (604)

More information

Practical Aspects and Typing Strategy in Molecular ABO and RH Blood Group Diagnosis

Practical Aspects and Typing Strategy in Molecular ABO and RH Blood Group Diagnosis East West Immunogenetics Conference Prague, Czech Republic March 5 6, 2009 Practical Aspects and Typing Strategy in Molecular ABO and RH Blood Group Diagnosis M a r t i n a P r a g e r prager.martina@bag-healthcare.com

More information

INTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3)

INTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3) PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Address Email Address PART II (MUST BE COMPLETED AND SIGNED BY LABORATORY MANAGEMENT* OR EMPLOYER IN ORDER TO BE ACCEPTABLE) SUBJECT: VERIFICATION

More information

SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2, 3, & 4)

SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2, 3, & 4) PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Last Four Digits of Applicant s Social Security # Address Email Address Daytime Telephone Number PART II (MUST BE COMPLETED AND SIGNED BY THE IMMEDIATE

More information

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD Platelet Refractoriness: The Basics Martin H. Bluth, MD, PhD Complete Toxicology Laboratories, LLC Objectives Define platelet refractoriness and associated conditions that may cause platelet refractoriness.

More information

Mechanisms of extravascular destruction of red cells coated with IgG1 or IgG3 (± C3b).

Mechanisms of extravascular destruction of red cells coated with IgG1 or IgG3 (± C3b). Introduction - Antibodies involved in transfusion reactions are of two types, namely the complete and the incomplete. - whereas the complete antibodies agglutinate red cells in saline medium, the incomplete

More information

FORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458

FORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458 Chapter 8 FORENSIC SEROLOGY 8-1 Nature of Blood The word blood refers to a highly complex mixture of cells, enzymes, proteins, and inorganic substances. Plasma, which is the fluid portion of blood, is

More information

Antibody Identification: Art or Science? A Case Study Approach

Antibody Identification: Art or Science? A Case Study Approach Antibody Identification: Art or Science? A Case Study Approach (Questions and Answers) Editors Janis R. Hamilton, MS, MT(ASCP)SBB Susan T. Johnson, MSTM, MT(ASCP)SBB Sally V. Rudmann, PhD, MT(ASCP)SBB

More information

Serological Testing: Why we did what we did!

Serological Testing: Why we did what we did! Serological Testing: Why we did what we did! W. John Judd, FIBMS, MIBiol Emeritus Professor University of Michigan What we did Provided blood and blood products in a timely, cost-efficient manner. Implemented

More information

DARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING. Dr. Jennifer Duncan Hematopathology Resident March 18, 2017

DARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING. Dr. Jennifer Duncan Hematopathology Resident March 18, 2017 DARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING Dr. Jennifer Duncan Hematopathology Resident March 18, 2017 Goals and Objectives: Briefly describe the use of dara in the treatment of

More information

Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients?

Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients? Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients? E. A. Scharberg, S. Seyboth, K. Panter, A. Ernst, J. Hagel, E. Richter, G. Rink, K. Janetzko,

More information

ORIGINAL ARTICLE. The persistence of red cell alloantibodies. Roberto Reverberi

ORIGINAL ARTICLE. The persistence of red cell alloantibodies. Roberto Reverberi ORIGINAL ARTICLE The persistence of red cell alloantibodies Roberto Reverberi Servizio di Immunoematologia e Trasfusionale Cesare Menini, Arcispedale S.Anna, Azienda Ospedaliera - Universitaria di Ferrara,

More information

Serological Tools For Investigating Problems In Immunohaematology

Serological Tools For Investigating Problems In Immunohaematology Serological Tools For Investigating Problems In Immunohaematology Dr.K.Vasantha Deputy Director (Retd.) National Institute of Immunohaematology (ICMR) Parel, Mumbai Immunohaematology is an application

More information

e-grips Module 18 Introduction to Antibody Identification

e-grips Module 18 Introduction to Antibody Identification Introduction to Antibody Identification Introduction Objectives After completing the learning module, the learner will be able to: 1. Discuss the limitations of antibody detection and identification. 2.

More information

GUIDELINES for PRETRANSFUSION LABORATORY PRACTICE

GUIDELINES for PRETRANSFUSION LABORATORY PRACTICE Australian & New Zealand Society of Blood Transfusion Ltd 5 th Edition, March 2007 GUIDELINES for PRETRANSFUSION LABORATORY PRACTICE i Copyright by The Australian & New Zealand Society of Blood Transfusion

More information

When, autoimmune hemolytic anemia

When, autoimmune hemolytic anemia IMMUNOHEMATOLOGY Adsorption of autoantibodies in the presence of LISS to detect alloantibodies underlying warm autoantibodies Jacques Chiaroni, Mohammed Touinssi, Magali Mazet, Philippe de Micco, and Virginie

More information

Handouts 4/5/2016. BCA Members willing to genotype your samples on Immucor PreciseType HEA

Handouts 4/5/2016. BCA Members willing to genotype your samples on Immucor PreciseType HEA BCA Members willing to genotype your samples on Immucor PreciseType HEA Community Blood Center - Dayton Blood Bank of Delmarva Indiana Blood Center LifeServe Blood Center LifeShare Blood Centers LifeSouth

More information

GUIDELINES FOR PRETRANSFUSION TESTING : PART I

GUIDELINES FOR PRETRANSFUSION TESTING : PART I Commissie voor Klinische Biologie Commission de Biologie Clinique GUIDELINES FOR PRETRANSFUSION TESTING : PART I Dr. A. Vanhonsebrouck, Bloedtransfusiecentrum Antwerpen 26-03-2009 WIV congress Rue Juliette

More information

The Bloodgen project : Platform Technology for Mass Scale Genotyping of Blood Groups and Beyond. Prof. Neil D. Avent and Bloodgen consortium members

The Bloodgen project : Platform Technology for Mass Scale Genotyping of Blood Groups and Beyond. Prof. Neil D. Avent and Bloodgen consortium members The Bloodgen project : Platform Technology for Mass Scale Genotyping of Blood Groups and Beyond Prof. Neil D. Avent and Bloodgen consortium members DGTI Symposium SY1 Friday 24 th September 2004 Bloodgen

More information

Reagent Red Blood Cells 0.8% Surgiscreen For the Detection of Unexpected Blood Group Antibodies Using the ID-Micro Typing System Gel Test Methods

Reagent Red Blood Cells 0.8% Surgiscreen For the Detection of Unexpected Blood Group Antibodies Using the ID-Micro Typing System Gel Test Methods Reagent Red Blood Cells 0.8% Surgiscreen For the Detection of Unexpected Blood Group Antibodies Using the ID-Micro Typing System Gel Test Methods Revised October 2015 REF 6902316 Rx ONLY SUMMARY AND EXPLANATION

More information

Red cell alloantibodies

Red cell alloantibodies 17 Identification of Alloantibodies to Red Cell Antigens Red cell alloantibodies other than non-red-cell-stimulated anti-a or -B are called unexpected red cell alloantibodies and may be found in 0.3-38%

More information

For order enquiries. Telephone Fax For technical information

For order enquiries. Telephone Fax For technical information Sanquin is responsible for safe and efficient blood supply in the Netherlands on a not-for-profit basis. Sanquin also develops and produces pharmaceutical products, conducts high-quality scientific research,

More information

ORIGINAL PAPER. Introduction

ORIGINAL PAPER. Introduction ORIGINAL PAPER Vox Sanguinis (2011) ª 2011 The Author(s) Vox Sanguinis ª 2011 International Society of Blood Transfusion DOI: 10.1111/j.1423-0410.2011.01507.x Prevalence and specificity of red-blood-cell

More information

High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors

High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors ORIGINAL PAPER ª 2011 The Author(s) Vox Sanguinis ª 2011 International Society of Blood Transfusion DOI: 10.1111/j.1423-0410.2011.01542.x High-throughput multiplex PCR genotyping for 35 red blood cell

More information

Subject: CPT/HCPCS Codes Effective for Medi-Cal On or After February 1, 2018

Subject: CPT/HCPCS Codes Effective for Medi-Cal On or After February 1, 2018 4665 Business Center Drive Fairfield, California 94534 Date: 3/19/18 Medi-Cal Important Provider Notice: #310 Subject: CPT/HCPCS Codes Effective for Medi-Cal On or After February 1, 2018 The 2018 updates

More information

Sanquin Blood Grouping Reagents

Sanquin Blood Grouping Reagents Sanquin Blood Grouping Reagents Blood grouping reagents are essential tools for diagnostic laboratories specialised in serology. The broad range of reagents developed by Sanquin Reagents is used in several

More information

Molecular characterisation of weak Lu a and Lu b expression associated with altered LU*01 and LU*02 alleles

Molecular characterisation of weak Lu a and Lu b expression associated with altered LU*01 and LU*02 alleles Molecular characterisation of weak Lu a and Lu b expression associated with altered LU*01 and LU*02 alleles Vanja Karamatic Crew 1, Ben Jones 1, Karen DeSay 1, Rosalind Laundy 1, Piers Walser 1, Alan Gray

More information

Paul Ashford Executive Director ICCBBA

Paul Ashford Executive Director ICCBBA Introduction to ISBT 128 Paul Ashford Executive Director ICCBBA ICCBBA ICCBBA enhances safety for patients by managing the ISBT 128 international information standard for use in transfusion and transplantation.

More information

Blood Typing Monoclonal Antibodies. Blood typing intermediates for further manufacturing use

Blood Typing Monoclonal Antibodies. Blood typing intermediates for further manufacturing use Blood Typing Monoclonal Antibodies Blood typing intermediates for further manufacturing use Merck Millipore, your partner for monoclonal blood typing antibodies For more than 25 years we have been leading

More information

Requirements of IBTO (AABB) Standards d for a Blood Transfusion Request 1.Positive identification of the recipient and the recipient blood samples.

Requirements of IBTO (AABB) Standards d for a Blood Transfusion Request 1.Positive identification of the recipient and the recipient blood samples. Detection and Identification of alloantibodies to Red Cell Antigens Antibody Screen Test Iranian Blood Transfusion Organization Mostafa Moghaddam MS, CLS ( ASCP ) BB Head of Immunohematology Reference

More information

Jaundiced Baby. Introduction to the Patient-Oriented Problem-Solving (POPS) System

Jaundiced Baby. Introduction to the Patient-Oriented Problem-Solving (POPS) System Jaundiced Baby Developed by Larry J. McCumber, PhD Parker A. Small, Jr, MD Department of Immunology and Medical Microbiology College of Medicine University of Florida Gainesville, Florida Modified by G.

More information

PRETRANSFUSION OR COMPATIBILITY TESTING

PRETRANSFUSION OR COMPATIBILITY TESTING 13 PRETRANSFUSION OR COMPATIBILITY TESTING 13.1 INTRODUCTION Pretransfusion compatibility testing serves to select a compatible unit of blood for the recipient which when transfused does not cause any

More information

Classification under the IVD Regulation

Classification under the IVD Regulation Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%

More information

Guidelines for compatibility procedures in blood transfusion laboratories

Guidelines for compatibility procedures in blood transfusion laboratories Transfusion Medicine, 2004, 14, 59 73 GUIDELINES Guidelines for compatibility procedures in blood transfusion laboratories Working Party of the British Committee for Standards in Haematology Blood Transfusion

More information

STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA

STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA TITLE: STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA 1.0 Principle 1.1 The purpose of quality control

More information

Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4

Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4 Laboratory: Document Type: Original Date Adopted: Previous Document: Transfusion Services Procedure 04/01/02 TRB-9 Revision 4 Document Author: Document Owner: Acknowledgement / Required Copy Holders*:

More information

Component Preparation, Manufacturing and Modifications

Component Preparation, Manufacturing and Modifications Component Preparation, Manufacturing and Modifications Mahdokht Parsi, MPH, MT(ASCP) Director of Operation, Immunohematology & Genomics Mparsi@nybc.org Current Practices in Transfusion Medicine 1 NEW YORK

More information

Introduction to Pharmacogenetics Competency

Introduction to Pharmacogenetics Competency Introduction to Pharmacogenetics Competency Updated on 6/2015 Pre-test Question # 1 Pharmacogenetics is the study of how genetic variations affect drug response a) True b) False Pre-test Question # 2 Pharmacogenetic

More information

Carol A Starks MS, MLS(ASCP), CLS. castarks

Carol A Starks MS, MLS(ASCP), CLS. castarks Carol A Starks MS, MLS(ASCP), CLS Brief review of the common blood groups ABO Rh Kell Duffy Kidd P Lutheran MNS Lewis Basic Blood Bank workups ABO discrepancies Single antibody not demonstrating Single

More information

Rh Molecular Testing

Rh Molecular Testing Rh Molecular Testing Future Webinars October 31 December 6 HLA: Transfusion and Transplant Running a Remote Transfusion Service Link to register: https://immucor.webinato.com/register All Content 2015

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 22 February 2006 EMEA/CHMP/BMWP/42832/2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON SIMILAR

More information

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Joy Gould BB(ASCP)C, SBB, CQIA(ASQ), CPHQ Thomas Jefferson University Hospital Philadelphia, PA Objectives Define Multiple

More information

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects. Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated

More information

Original Equipment Manufacturing. Intermediate and OEM Products for Immunohaematology

Original Equipment Manufacturing. Intermediate and OEM Products for Immunohaematology Original Equipment Manufacturing Intermediate and OEM Products for Immunohaematology A long history as an OEM manufacturer For over 30 years, Quotient has developed, manufactured and marketed high quality

More information

Annals of Alquds Medicine (٢٠٠٩) Issue ٥ : ١٨-٢٧

Annals of Alquds Medicine (٢٠٠٩) Issue ٥ : ١٨-٢٧ Original Article RHD Gene Polymorphism among Palestinians of Gaza Strip. Dawoud M.I. 1, Shubair M.E. 2, Sharif F.A. 2* 1. Al-Shifa Hospital, Central Blood Bank, Gaza. 2. Medical Technology Department,

More information

GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY

GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY GUIDELINES FOR ISSUING AND RETURNING BLOOD COMPONENTS AND BLOOD PRODUCTS WITHIN A FACILITY 1. Policy Statement 1.1 A policy shall be in place to ensure traceability of all blood components and blood products

More information

Blood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B

Blood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B Blood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B English, B186363, Version 06, 2017.03 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S. LICENSE NUMBER:

More information

ABO Typing Discrepancies

ABO Typing Discrepancies Jayme Heimonen MT(ASCP)SBB Blood Bank Technical Specialist Borgess Medical Center Kalamazoo, MI ASCLS-Michigan 2016 1 Expected reactions are missing 4+ 0 4+ 0 0 0 0 0 4+ 0 0 3+ 2 Unexpected reactions are

More information

DTT Treated Reagent Red Cells for use in Resolving DARA Interference. More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB

DTT Treated Reagent Red Cells for use in Resolving DARA Interference. More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB DTT Treated Reagent Red Cells for use in Resolving DARA Interference More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB Daratumumab Anti-myeloma and anti-lymphoma agent known to interfere with routine Blood

More information

NHSBT Portfolio of Blood Components and Guidance for their Clinical Use. Summary of Significant Changes. Purpose. Definitions. Applicable Documents

NHSBT Portfolio of Blood Components and Guidance for their Clinical Use. Summary of Significant Changes. Purpose. Definitions. Applicable Documents This Specification replaces SPN223/7 Copy Number Effective: 21/12/16 Summary of Significant Changes Introduction of HEV testing, and Pooled Platelets in Plasma/Additive mixture Amendment to interruption

More information

Understanding DARZALEX Interference With Blood Compatibility Testing

Understanding DARZALEX Interference With Blood Compatibility Testing Understanding DARZALEX Interference With Blood Compatibility Testing DARZALEX (daratumumab) Results in a False Positive Indirect Coombs Test DARZALEX is a human monoclonal antibody for the treatment of

More information

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1) Clinical Laboratory s of Practice The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services

More information

Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development

Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development 1 2 3 24 June 2010 EMA/CHMP/641298/2008 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug

More information

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Joy Gould BB(ASCP)C, SBB, CQIA(ASQ), CPHQ Thomas Jefferson University Hospital Philadelphia, PA Objectives Define Multiple

More information

Bachelor of Science (Hons) / Bachelor of Science Biomedical Science

Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Bachelor of Science (Hons) / Bachelor of Science Biomedical Science Awarded by In collaboration with This degree course is designed to give you a broad understanding of the scientific investigation of

More information

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS

GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS GUIDANCE ON THE EVALUATION OF NON ACCREDITED QUALIFICATIONS 1. Introduction 1.1 This document provides guidance notes for the assessment of academic qualifications that have not been formally accredited

More information

STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD

STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD TITLE: STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION TUBE METHOD 1.0 Principle An antibody identification procedure is

More information

Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group

Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Key changes in new BCSH Transfusion I.T. Guidelines Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Membership Joan Jones Head of Quality, Welsh Blood Service Paul Ashford

More information

ICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions. Step 3

ICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions. Step 3 European Medicines Agency June 2009 EMEA/CHMP/ICH/380636/2009 ICH Topic E16 Genomic Biomarkers Related to Drug Response: Context, Structure and Format of Qualification Submissions Step 3 NOTE FOR GUIDANCE

More information

WHO Biological Standards And. Genetic Reference Materials

WHO Biological Standards And. Genetic Reference Materials WHO Biological Standards And Genetic Reference Materials Elaine Gray and Paul Metcalfe Genetic Reference Materials Gene Medicine Group National Institute for Biological Standards and Control United Kingdom

More information

Discussion. Principle. Laboratory Procedure Manual EXERCISE 3. Blaney, Chapter 4 The ABO and H Blood Group Systems. Textbook: 20 points.

Discussion. Principle. Laboratory Procedure Manual EXERCISE 3. Blaney, Chapter 4 The ABO and H Blood Group Systems. Textbook: 20 points. Exercise 3 ABO and D Typing Textbook: Blaney, Chapter 4 The ABO and H Blood Group Systems Skills: 20 points Objectives 1. Explain why the ABO blood groups are the most significant of all blood group systems.

More information

IMMUNOHEMATOLOGY. The molecular basis of the Rhesus antigen E w

IMMUNOHEMATOLOGY. The molecular basis of the Rhesus antigen E w Blackwell Science, LtdOxford, UKTRFTransfusion0041-11322004 American Association of Blood BanksMarch 2004443Original ArticleMOLECULAR BASIS OF THE RHESUS ANTIGEN EWSTROBEL ET AL. IMMUNOHEMATOLOGY The molecular

More information

DNA Typing of the Human MN and Ss Blood Group Antigens in Amniotic Fluid and Following Massive Transfusion

DNA Typing of the Human MN and Ss Blood Group Antigens in Amniotic Fluid and Following Massive Transfusion COAGULATION AND TRANSFUSION MEDICINE DNA Typing of the Human MN and Ss Blood Group Antigens in Amniotic Fluid and Following Massive Transfusion JAMES R. ESHLEMAN, MD, PHD, SUSAN H. SHAKIN-ESHLEMAN, MD,

More information

Summer 2007 IN A DIFFERENT VEIN

Summer 2007 IN A DIFFERENT VEIN Michigan Association of Blood Banks presents Summer 2007 IN A DIFFERENT VEIN Michigan Association of Blood Banks, c/o Lisa Tyzo, 29832 Buckingham, Livonia MI 48154 www.mabb.org MABB_lisa@yahoo.com 734-422-3630

More information

Correspondence should be addressed to Dietmar Enko;

Correspondence should be addressed to Dietmar Enko; Blood Transfusion, Article ID 532919, 5 pages http://dx.doi.org/10.1155/2014/532919 Research Article Frequencies and Specificities of Enzyme-Only Detected Erythrocyte Alloantibodies in Patients Hospitalized

More information

Forecast diagnostics for antimicrobial resistance (AMR)

Forecast diagnostics for antimicrobial resistance (AMR) Forecast diagnostics for antimicrobial resistance (AMR) Authors: Ann Van den Bruel, Philip Turner NIHR Diagnostic Evidence Cooperative Oxford, University of Oxford Context When asked to make forecasts

More information

Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel )

Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel ) Transfusion Medicine, 2011, 21, 90 98 doi: 10.1111/j.1365-3148.2010.01054.x ORIGINAL ARTICLE Multi-centre evaluation of pre-transfusional routine tests using 8-column format gel cards (DG Gel ) J. Taylor,

More information

Table of Contents. Preface... xv. Editorial Comments... xvii. About the Authors... xix

Table of Contents. Preface... xv. Editorial Comments... xvii. About the Authors... xix Preface................................................................... xv Editorial Comments........................................................ xvii About the Authors..........................................................

More information

DISTRIBUTION OF ABO GENOTYPES AND ALLELE FREQUENCIES IN A KOREAN POPULATION

DISTRIBUTION OF ABO GENOTYPES AND ALLELE FREQUENCIES IN A KOREAN POPULATION Jpn J Human Genet 42, 331-335, 1997 DISTRIBUTION OF ABO GENOTYPES AND ALLELE FREQUENCIES IN A KOREAN POPULATION Sung Ha KANG, x'2 Yasuo FUKUMORI, 1'* Shiro OHNOKI, 1 Hirotoshi SHIBATA, 1 Kyou Sup HAN,

More information

This position is in the Joint Office of Strategic Planning. This position is for the Medical School Campus.

This position is in the Joint Office of Strategic Planning. This position is for the Medical School Campus. Planning Associate - Joint Office of Strategic Planning 33673 Washington University School of Medicine in St. Louis MO This position is full-time and works approximately 40 hours per week. Department Name/Job

More information

http://www.simonmawer.com/mendel's_garden.jpg 1 http://khzs.fme.vutbr.cz/iahrwg2009/img/map_cz.gif 2 http://www.haverford.edu/biology/meneely/brno.htm 3 http://biology.clc.uc.edu/fankhauser/travel/berlin/for_web/

More information

VII. Rh Blood Group System

VII. Rh Blood Group System VII. Rh Blood Group System A. The Rh system is one of the most complex genetic systems, and certain aspects of its genetics, nomenclature and antigenic interactions are unsettled. The aim of this lecture

More information

Small Interfering RNA s Molecular biology and use in therapy

Small Interfering RNA s Molecular biology and use in therapy Small Interfering RNA s Molecular biology and use in therapy Dr Stuart Hamilton - NHMRC Early Career Fellow Serology and Virology Division, SEALS Microbiology, Prince of Wales Hospital; School of Women

More information

MLAB IMMUNOHEMATOLOGY

MLAB IMMUNOHEMATOLOGY Course Syllabus MLAB 2431- IMMUNOHEMATOLOGY Catalog Description: A study of blood antigens and antibodies. Presents quality control, basic laboratory technique and safety. Includes the principles, procedures

More information

Resolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies

Resolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies Revised October 2015 Reagent Red Blood Cells Resolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies 719510 Rx ONLY SUMMARY AND EXPLANATION When an unexpected antibody

More information

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy Guidance for Industry and FDA Staff Replacement Reagent and Instrument Family Policy Document issued on: December 11, 2003 This document supersedes Data for Commercialization of Original Equipment Manufacturers

More information

Revised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion

Revised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion Revised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion Robin Thorpe & Meenu Wadhwa Revised Guideline: Differences from original

More information

Department of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion

Department of Research Evaluation. Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion Department of Research Evaluation report on research unit: Biology and pharmacology of blood platelets: haemostasis, thrombosis, transfusion Under the supervision of the following institutions and research

More information

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development) Strategies for modern biomarker and drug - Oct 3, 2014 Sequencing the cancer genome

More information

Application of Real-Time PCR and Melting Curve Analysis in Rapid Detection of A el and B el Blood Types

Application of Real-Time PCR and Melting Curve Analysis in Rapid Detection of A el and B el Blood Types Annals of Clinical & Laboratory Science, vol. 35, no. 1, 2005 25 Application of Real-Time PCR and Melting Curve Analysis in Rapid Detection of A el and B el Blood Types Ding-Ping Chen, 1 Ching-Ping Tseng,

More information

Standards of proficiency. Biomedical scientists

Standards of proficiency. Biomedical scientists Standards of proficiency Biomedical scientists Contents Foreword 1 Introduction 3 Standards of proficiency 7 Foreword We are pleased to present the Health and Care Professions Council s standards of proficiency

More information

Quality Assurance by Liz McChlery

Quality Assurance by Liz McChlery Quality Assurance by Liz McChlery Define QA and Total Quality Management Describe Quality Control Define and distinguish Accuracy and Precision Define a Biological Reference Interval Describe ISO15189

More information

LABORATORY TRAINING LOGBOOK

LABORATORY TRAINING LOGBOOK REGISTRATION TRAINING PORTFOLIO FOR THE IBMS CERTIFICATE OF COMPETENCE LABORATORY TRAINING LOGBOOK Version 4.1 www.ibms.org Trainee record details Registration Training Portfolio Case No: Surname: First

More information

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December

More information

CAP Accreditation Checklists 2017 Edition

CAP Accreditation Checklists 2017 Edition CAP Accreditation Checklists 2017 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight

More information

UCL HUMAN RESOURCES DIVISION. UCL Advert Templates

UCL HUMAN RESOURCES DIVISION. UCL Advert Templates UCL HUMAN RESOURCES DIVISION UCL Advert Templates Helen Brown Page 1 of 18 10 December 2009 CONTENTS Preparing an Advert... 3 Sample Adverts... 5 Academic Vacancy... 5 Administrative and Support Vacancy...

More information

ABO Blood Group Discrepancies: Causes And resolution

ABO Blood Group Discrepancies: Causes And resolution ABO Blood Group Discrepancies: Causes And resolution Indian journal of tranffusion Medicine Introduction The ABO system contains four major ABO phenotypes: A, B, O and AB. The four phenotypes are determined

More information

Kell Blood Group System (KEL) ISBT 006

Kell Blood Group System (KEL) ISBT 006 Kell, Duffy, Kidd Objectives: Kell, Kidd and Duffy Kell and Duffy in 30 minutes you ve got to be Kidd-ing! (Ok, we ll talk about Kidd, too) Jessica Drouillard, SBB(ASCP) CM Heartland Blood Centers, part

More information

Multiple Myeloma Research Foundation 2014 Research Fellow Award Program Guidelines

Multiple Myeloma Research Foundation 2014 Research Fellow Award Program Guidelines Multiple Myeloma Research Foundation 2014 Research Fellow Award Program Guidelines Program Description: MULTIPLE MYELOMA RESEARCH FOUNDATION 2014 RESEARCH FELLOW AWARD The Multiple Myeloma Research Foundation

More information

Building on the NHLBI Legacy of Hypertension Research:

Building on the NHLBI Legacy of Hypertension Research: Building on the NHLBI Legacy of Hypertension Research: Charting Our Future Together Gary H. Gibbons, M.D. Director National Heart, Lung, and Blood Institute AHA Council on Hypertension September 16, 2015

More information

Exam MOL3007 Functional Genomics

Exam MOL3007 Functional Genomics Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting

More information

CONTINUOUS PRACTICAL ASSESSMENT FORM

CONTINUOUS PRACTICAL ASSESSMENT FORM Department of Radiography Student Name Placement Date Named radiographer CONTINUOUS PRACTICAL ASSESSMENT FORM Current Year/Term Previous placement date / total weeks on this unit type Duration of placement

More information

Rare diseases in the 7th EU Framework Programme for Research and Technological Development

Rare diseases in the 7th EU Framework Programme for Research and Technological Development Rare diseases in the 7th EU Framework Programme for Research and Technological Development Manuel Hallen, MD Head of Unit Medical & Public Health Research DG Research European Commission 1 The role of

More information